Skip to content
DataLookout
Start free
Menu

NCT06098430

Patient-Reported Outcomes and Quality of Life in Adult and Pediatric Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)

StatusRecruiting
PhaseNot specified
Primary completion (estimated)

At risk: Primary completion moved at least 2 years 1 month later.

See at-risk trials from St. Jude Children's Research Hospital

Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 17 versions: 16 with changes below, 1 re-verified with no change. See every version on ClinicalTrials.gov ↗

  1. Primary completion pushed from Dec 31, 2026 to Feb 2029
    • Eligibility criteria expanded, about 9 words
    • Study completion pushed from Jan 31, 2028 to Mar 2030
    • Site details revised at 1 of 7 sites
  2. Study sites revised (7)v16
  3. Study sites: 5 to 7v15
  4. Study sites: 4 to 5v14
  5. Study sites: 3 to 4v13
Show 10 earlier versionsHide 10 earlier versions
  1. Site details revised at 1 of 3 sitesv11
  2. Study sites: 2 to 3v10
  3. Eligibility criteria expanded, about 26 wordsv9
  4. Start date changed from estimate of Apr 2024 to Apr 4, 2024v8
  5. Eligibility criteria shortened, about 4 words
    • Start date: Mar 2024 to Apr 2024
    • Site contacts updated at 1 of 2 sites
    v7
  6. Start date: Feb 2024 to Mar 2024v6
  7. Start date: Jan 2024 to Feb 2024v5
  8. Start date: Dec 2023 to Jan 2024v4
  9. Start date: Nov 2023 to Dec 2023
    • Site contacts updated at 1 of 2 sites
    v3
  10. Trial status: Not Yet Recruiting to Recruiting
    • Site details revised at 2 of 2 sites
    v2
  1. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Estimates of response rates
Timeframe: At baseline, 3, 6, 9, and 12 months
Patterns of individual per-patient survey completion
Timeframe: At baseline, 3, 6, 9, and 12 months

Sites

7 sites in 1 country